Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study.

Langhorne P, O'Donnell MJ, Chin SL, Zhang H, Xavier D, Avezum A, Mathur N, Turner M, MacLeod MJ, Lopez-Jaramillo P, Damasceno A, Hankey GJ, Dans AL, Elsayed A, Mondo C, Wasay M, Czlonkowska A, Weimar C, Yusufali AH, Hussain FA, Lisheng L, Diener HC, Ryglewicz D, Pogosova N, Iqbal R, Diaz R, Yusoff K, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Magazi D, Nilanont Y, Rosengren A, Oveisgharan S, Yusuf S; INTERSTROKE collaborators.

Lancet. 2018 May 19;391(10134):2019-2027. doi: 10.1016/S0140-6736(18)30802-X. Epub 2018 May 17.

PMID:
29864018
2.

Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3.

Nazari F, Sinaei F, Nilipour Y, Petit F, Oveisgharan S, Nassiri-Toosi M, Razzaghy-Azar M, Mahmoudi M, Nafissi S.

J Clin Neuromuscul Dis. 2018 Jun;19(4):203-210. doi: 10.1097/CND.0000000000000212.

PMID:
29794575
3.

APOE ε2ε4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults.

Oveisgharan S, Buchman AS, Yu L, Farfel J, Hachinski V, Gaiteri C, De Jager PL, Schneider JA, Bennett DA.

Neurology. 2018 Jun 12;90(24):e2127-e2134. doi: 10.1212/WNL.0000000000005677. Epub 2018 May 11.

PMID:
29752306
4.

Ten-year trend in stroke incidence and its subtypes in Isfahan, Iran during 2003-2013.

Bahonar A, Khosravi A, Khorvash F, Maracy M, Oveisgharan S, Mohammadifard N, Saadatnia M, Nouri F, Sarrafzadegan N.

Iran J Neurol. 2017 Oct 7;16(4):201-209.

5.

Risk and Age of Cardiovascular Event in Women with Metabolic Syndrome: Menopause Age in Focus.

Soleimani A, Pourmoghaddas A, Sadeghi M, Roohafza H, Talaei M, Dianatkhah M, Oveisgharan S, Soleimani M, Sarrafzadegan N.

Metab Syndr Relat Disord. 2018 Apr;16(3):127-134. doi: 10.1089/met.2017.0096. Epub 2018 Feb 13.

PMID:
29437523
6.

Correction: PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region.

Sarrafzadegan N, Hassannejad R, Marateb HR, Talaei M, Sadeghi M, Roohafza HR, Masoudkabir F, Oveisgharan S, Mansourian M, Mohebian MR, Mañanas MA.

PLoS One. 2018 Jan 25;13(1):e0191379. doi: 10.1371/journal.pone.0191379. eCollection 2018.

7.

PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region.

Sarrafzadegan N, Hassannejad R, Marateb HR, Talaei M, Sadeghi M, Roohafza HR, Masoudkabir F, Oveisgharan S, Mansourian M, Mohebian MR, Mañanas MA.

PLoS One. 2017 Dec 19;12(12):e0189389. doi: 10.1371/journal.pone.0189389. eCollection 2017. Erratum in: PLoS One. 2018 Jan 25;13(1):e0191379.

8.

Whole milk consumption and risk of cardiovascular disease and mortality: Isfahan Cohort Study.

Talaei M, Hosseini N, van Dam RM, Sadeghi M, Oveisgharan S, Dianatkhah M, Sarrafzadegan N.

Eur J Nutr. 2017 Nov 18. doi: 10.1007/s00394-017-1581-1. [Epub ahead of print]

PMID:
29151136
9.

Cardiovascular disease events and its predictors in women: Isfahan Cohort Study (ICS).

Sadeghi M, Soleimani A, Roohafza H, Yazdekhasti S, Oveisgharan S, Talaei M, Sarrafzadegan N.

J Cardiovasc Thorac Res. 2017;9(3):158-163. doi: 10.15171/jcvtr.2017.27. Epub 2017 Aug 21.

10.

Enhancement of Motor Recovery through Left Dorsolateral Prefrontal Cortex Stimulation after Acute Ischemic Stroke.

Oveisgharan S, Organji H, Ghorbani A.

J Stroke Cerebrovasc Dis. 2018 Jan;27(1):185-191. doi: 10.1016/j.jstrokecerebrovasdis.2017.08.026. Epub 2017 Sep 8.

PMID:
28893574
11.

Mendelian Genes and Risk of Intracerebral Hemorrhage and Small-Vessel Ischemic Stroke in Sporadic Cases.

Chong M, O'Donnell M, Thijs V, Dans A, López-Jaramillo P, Gómez-Arbeláez D, Mondo C, Czlonkowska A, Skowronska M, Oveisgharan S, Yusuf S, Paré G.

Stroke. 2017 Aug;48(8):2263-2265. doi: 10.1161/STROKEAHA.117.017322. Epub 2017 Jul 5.

PMID:
28679849
12.

Determinants of Incident Metabolic Syndrome in a Middle Eastern Population: Isfahan Cohort Study.

Hosseini N, Talaei M, Dianatkhah M, Sadeghi M, Oveisgharan S, Sarrafzadegan N.

Metab Syndr Relat Disord. 2017 Sep;15(7):354-362. doi: 10.1089/met.2016.0156. Epub 2017 Jul 5.

PMID:
28677982
13.

Atherosclerosis and vascular cognitive impairment neuropathological guideline.

Oveisgharan S, Hachinski V.

Brain. 2017 Feb;140(2):e12. doi: 10.1093/brain/aww304. Epub 2016 Dec 21. No abstract available.

PMID:
28007992
14.

Impaired arterial smooth muscle cell vasodilatory function in methamphetamine users.

Nabaei G, Oveisgharan S, Ghorbani A, Fatehi F.

J Neurol Sci. 2016 Nov 15;370:107-111. doi: 10.1016/j.jns.2016.09.027. Epub 2016 Sep 17.

PMID:
27772737
15.

Metabolic Syndrome and the Risk of Ischemic Stroke.

Sarrafzadegan N, Gharipour M, Sadeghi M, Nezafati P, Talaie M, Oveisgharan S, Nouri F, Khosravi A.

J Stroke Cerebrovasc Dis. 2017 Feb;26(2):286-294. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.019. Epub 2016 Oct 18.

PMID:
27769610
16.

Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.

O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, Lopez-Jaramillo P, Damasceno A, Langhorne P, McQueen MJ, Rosengren A, Dehghan M, Hankey GJ, Dans AL, Elsayed A, Avezum A, Mondo C, Diener HC, Ryglewicz D, Czlonkowska A, Pogosova N, Weimar C, Iqbal R, Diaz R, Yusoff K, Yusufali A, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Oveisgharan S, Al Hussain F, Magazi D, Nilanont Y, Ferguson J, Pare G, Yusuf S; INTERSTROKE investigators.

Lancet. 2016 Aug 20;388(10046):761-75. doi: 10.1016/S0140-6736(16)30506-2. Epub 2016 Jul 16.

PMID:
27431356
17.

Case fatality rate ‎and disability of stroke in Isfahan, Iran: Isfahan stroke registry.

Oveisgharan S, Ghaemmaghami AB, Bahonar A, Sarrafzadegan N.

Iran J Neurol. 2016 Jan 5;15(1):9-15.

18.

The impact of health-related quality of life on the incidence of ischaemic heart disease and stroke; a cohort study in an Iranian population.

Dadjou Y, Kermani-Alghoraishi M, Sadeghi M, Talaei M, Yousefy A, Oveisgharan S, Roohafza H, Rabiei K, Sarrafzadegan N.

Acta Cardiol. 2016 Apr;71(2):221-6. doi: 10.2143/AC.71.2.3141853.

PMID:
27090045
19.

Comparison between European and Iranian cutoff points of triglyceride/high-density lipoprotein cholesterol concentrations in predicting cardiovascular disease outcomes.

Gharipour M, Sadeghi M, Dianatkhah M, Nezafati P, Talaie M, Oveisgharan S, Golshahi J.

J Clin Lipidol. 2016 Jan-Feb;10(1):143-9. doi: 10.1016/j.jacl.2015.10.008. Epub 2015 Oct 24.

PMID:
26892131
20.

Do Cardiometabolic Risk Factors Relative Risks Differ for the Occurrence of Ischemic Heart Disease and Stroke?

Aalami Harandi S, Sarrafzadegan N, Sadeghi M, Talaei M, Dianatkhah M, Oveisgharan S, Pourmoghaddas A, Salehi A, Sedighifard Z.

Res Cardiovasc Med. 2016 Jan 6;5(1):e30619. doi: 10.5812/cardiovascmed.30619. eCollection 2016 Feb.

21.
22.

Evaluation of (99m)Tc-TRODAT-1 SPECT in the diagnosis of Parkinson's disease versus other progressive movement disorders.

Fallahi B, Esmaeili A, Beiki D, Oveisgharan S, Noorollahi-Moghaddam H, Erfani M, Tafakhori A, Rohani M, Fard-Esfahani A, Emami-Ardekani A, Geramifar P, Eftekhari M.

Ann Nucl Med. 2016 Feb;30(2):153-62. doi: 10.1007/s12149-015-1042-y. Epub 2015 Nov 26.

PMID:
26612262
23.

Executive dysfunction is a strong stroke predictor.

Oveisgharan S, Hachinski V.

J Neurol Sci. 2015 Feb 15;349(1-2):161-7. doi: 10.1016/j.jns.2015.01.010. Epub 2015 Jan 13.

PMID:
25614441
24.

The cumulative incidence of conventional risk factors of cardiovascular disease and their population attributable risk in an Iranian population: The Isfahan Cohort Study.

Sadeghi M, Talaei M, Oveisgharan S, Rabiei K, Dianatkhah M, Bahonar A, Sarrafzadegan N.

Adv Biomed Res. 2014 Nov 29;3:242. doi: 10.4103/2277-9175.145749. eCollection 2014.

25.

Determinants of incident prediabetes and type 2 diabetes in a 7-year cohort in a developing country: The Isfahan Cohort Study.

Sadeghi M, Talaei M, Parvaresh Rizi E, Dianatkhah M, Oveisgharan S, Sarrafzadegan N.

J Diabetes. 2015 Sep;7(5):633-41. doi: 10.1111/1753-0407.12236. Epub 2014 Dec 22.

PMID:
25350916
26.

Heart rate and cardiovascular events: a nested case-control in Isfahan Cohort Study.

Sadeghi M, Talaei M, Zand I, Oveisgharan S, Iranipour R, Esteki Ghashghaei F, Sarrafzadegan N.

Arch Iran Med. 2014 Sep;17(9):633-7. doi: 0141709/AIM.0010.

27.

A Case Report of Homocystinuria With Dystonia and Stroke.

Rezazadeh A, Oveisgharan S, Shahidi G, Naghdi R.

Child Neurol Open. 2014 Aug 26;1(1):2329048X14545870. doi: 10.1177/2329048X14545870. eCollection 2014 Jul-Sep.

28.

Comparison of competing risks models based on cumulative incidence function in analyzing time to cardiovascular diseases.

Dianatkhah M, Rahgozar M, Talaei M, Karimloua M, Sadeghi M, Oveisgharan S, Sarrafzadegan N.

ARYA Atheroscler. 2014 Jan;10(1):6-12.

29.

Incident hypertension and its predictors: the Isfahan Cohort Study.

Talaei M, Sadeghi M, Mohammadifard N, Shokouh P, Oveisgharan S, Sarrafzadegan N.

J Hypertens. 2014 Jan;32(1):30-8. doi: 10.1097/HJH.0b013e32836591d4.

PMID:
24048009
30.

Atrial fibrillation and the hachinski ischemic scale-reply.

Hachinski V, Oveisgharan S, Shankle WR.

Arch Neurol. 2012 Aug 1;69(8):1084-5. doi: 10.1001/archneurol.2012.1524. No abstract available.

PMID:
23753774
31.

Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study.

Talaei M, Sarrafzadegan N, Sadeghi M, Oveisgharan S, Marshall T, Thomas GN, Iranipour R.

Arch Iran Med. 2013 Mar;16(3):138-44. doi: 013163/AIM.004.

32.

The influence of gender and place of residence on cardiovascular diseases and their risk factors. The Isfahan cohort study.

Sarrafzadegan N, Talaei M, Kelishadi R, Toghianifar N, Sadeghi M, Oveisgharan S, Kabiri P, Tavassoli A, Mohammadifard N, Thomas GN, Marshall T.

Saudi Med J. 2012 May;33(5):533-40.

PMID:
22588815
33.

Appropriate cut-off values of waist circumference to predict cardiovascular outcomes: 7-year follow-up in an Iranian population.

Talaei M, Thomas GN, Marshall T, Sadeghi M, Iranipour R, Oveisgharan S, Sarrafzadegan N.

Intern Med. 2012;51(2):139-46. Epub 2012 Jan 15.

34.

Optimizing the Hachinski Ischemic Scale.

Hachinski V, Oveisgharan S, Romney AK, Shankle WR.

Arch Neurol. 2012 Feb;69(2):169-75. doi: 10.1001/archneurol.2011.1698. Epub 2011 Oct 10.

PMID:
21987392
35.

The Isfahan cohort study: rationale, methods and main findings.

Sarrafzadegan N, Talaei M, Sadeghi M, Kelishadi R, Oveisgharan S, Mohammadifard N, Sajjadieh AR, Kabiri P, Marshall T, Thomas GN, Tavasoli A.

J Hum Hypertens. 2011 Sep;25(9):545-53. doi: 10.1038/jhh.2010.99. Epub 2010 Nov 25.

PMID:
21107436
36.

Hypertension, executive dysfunction, and progression to dementia: the canadian study of health and aging.

Oveisgharan S, Hachinski V.

Arch Neurol. 2010 Feb;67(2):187-92. doi: 10.1001/archneurol.2009.312.

PMID:
20142526
37.

Effect of skin thickness on sensory nerve action potential amplitude.

Hasanzadeh P, Oveisgharan S, Sedighi N, Nafissi S.

Clin Neurophysiol. 2008 Aug;119(8):1824-1828. doi: 10.1016/j.clinph.2008.04.003. Epub 2008 May 19.

PMID:
18487083
38.

Stroke in Isfahan, Iran: hospital admission and 28-day case fatality rate.

Oveisgharan S, Sarrafzadegan N, Shirani S, Hosseini S, Hasanzadeh P, Khosravi A.

Cerebrovasc Dis. 2007;24(6):495-9. Epub 2007 Oct 29.

PMID:
17971627
39.

Standard method for developing stroke registers in low-income and middle-income countries: experiences from a feasibility study of a stepwise approach to stroke surveillance (STEPS Stroke).

Truelsen T, Heuschmann PU, Bonita R, Arjundas G, Dalal P, Damasceno A, Nagaraja D, Ogunniyi A, Oveisgharan S, Radhakrishnan K, Skvortsoya VI, Stakhovskaya V.

Lancet Neurol. 2007 Feb;6(2):134-9.

PMID:
17239800
40.

Barthel index in a Middle-East country: translation, validity and reliability.

Oveisgharan S, Shirani S, Ghorbani A, Soltanzade A, Baghaei A, Hosseini S, Sarrafzadegan N.

Cerebrovasc Dis. 2006;22(5-6):350-4. Epub 2006 Aug 3.

PMID:
16888374

Supplemental Content

Loading ...
Support Center